Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 6

Results: 12

L6H21 protects against cognitive impairment and brain pathologies via toll-like receptor 4-myeloid differentiation factor 2 signalling in prediabetic rats.

Published in:

2022

By:

Oo, Thura Tun;
Sumneang, Natticha;
Ongnok, Benjamin;
Arunsak, Busarin;
Chunchai, Titikorn;
Kerdphoo, Sasiwan;
Apaijai, Nattayaporn;
Pratchayasakul, Wasana;
Liang, Guang;
Chattipakorn, Nipon;
Chattipakorn, Siriporn C

Publication type:

journal article

Azithromycin alleviates the severity of rheumatoid arthritis by targeting the unfolded protein response component of glucose‐regulated protein 78 (GRP78).

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1201, doi. 10.1111/bph.15714

By:

Zhang, Yongli;
Ge, Luna;
Song, Guanhua;
Zhang, Ruojia;
Li, Shufeng;
Shi, Haojun;
Zhang, Hongchang;
Li, Yi;
Pan, Jihong;
Wang, Lin;
Han, Jinxiang

Publication type:

Article

Bacterial growth dynamics and pharmacokinetic–pharmacodynamic relationships of rifampicin and bedaquiline in BALB/c mice.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1251, doi. 10.1111/bph.15688

By:

Muliaditan, Morris;
Della Pasqua, Oscar

Publication type:

Article

Evidence for tetrodotoxin‐resistant spontaneous myogenic contractions of mouse isolated stomach that are dependent on acetylcholine.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1187, doi. 10.1111/bph.15685

By:

Cai, Weigang;
Makwana, Raj;
Straface, Marilisa;
Gharibans, Armen;
Andrews, Paul L. R.;
Sanger, Gareth J.

Publication type:

Article

A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1237, doi. 10.1111/bph.15678

By:

Sun, Zeren;
Xu, Dengqiu;
Zhao, Lei;
Li, Xihua;
Li, Sijia;
Huang, Xiaofei;
Li, Chunjie;
Sun, Lixin;
Liu, Bing;
Jiang, Zhenzhou;
Zhang, Luyong

Publication type:

Article

Novel drug developmental strategies for treatment‐resistant depression.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1146, doi. 10.1111/bph.15753

By:

Borbély, Éva;
Simon, Mária;
Fuchs, Eberhard;
Wiborg, Ove;
Czéh, Boldizsár;
Helyes, Zsuzsanna

Publication type:

Article

Withdrawal.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1284, doi. 10.1111/bph.15674

By:

Bank, Sarbashri;
Bhattacharya, Suman;
Koschinski, Andreas;
Zaccolo, Manuela;
Maiti, Smarajit;
Banerjee, Amrita;
De, Subrata Kumar;
Khan, Gausal A;
Das, Madhusudan;
Guha, Santanu;
Ghosh, Arjun;
Ray, Udayan;
Sinha, Asru K

Publication type:

Article

Implications of the effects of cannabigerolic acid on our understanding of the potential of phytocannabinoids in anti-seizure treatment.

Published in:

2022

By:

McNeish, Alister J

Publication type:

journal article

Sordarin— An anti‐fungal antibiotic with a unique modus operandi.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1125, doi. 10.1111/bph.15724

By:

Shao, Yutian;
Molestak, Eliza;
Su, Weike;
Stankevič, Marek;
Tchórzewski, Marek

Publication type:

Article

Oxoglaucine alleviates osteoarthritis by activation of autophagy via blockade of Ca<sup>2+</sup> influx and TRPV5/calmodulin/CAMK‐II pathway.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1282, doi. 10.1111/bph.15706

By:

Eid, Nabil;
Ito, Yuko

Publication type:

Article

Pharmacological characterization of novel heteromeric GluCl subtypes from Caenorhabditis elegans and parasitic nematodes.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1264, doi. 10.1111/bph.15703

By:

Lamassiaude, Nicolas;
Courtot, Elise;
Corset, Angélique;
Charvet, Claude L.;
Neveu, Cédric

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2022, v. 179, n. 6, p. 1123, doi. 10.1111/bph.15549
Publication type:: Article